Roche personalized cancer treatment to cost about $204,560 a year
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (Reuters) – Roche Holding AG has priced at about $ 204,560 a year its personalized cancer treatment, Rozlytrek, that targets tumors with specific genetic mutations, the Swiss drugmaker said. The treatment will cost about… Read More »